Literature DB >> 18421061

Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials.

Paul L Nguyen, Anthony V D'Amico.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18421061     DOI： 10.1200/JCO.2007.15.9939

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Authors:  Mack Roach; Jennifer Moughan; Colleen A F Lawton; Adam P Dicker; Kenneth L Zeitzer; Elizabeth M Gore; Young Kwok; Michael J Seider; I-Chow Hsu; Alan C Hartford; Eric M Horwitz; Kosj Yamoah; Christopher U Jones; Jeff M Michalski; W Robert Lee; Thomas M Pisansky; Rachel Rabinovitch; Marvin Rotman; Rodger M Pryzant; Harold E Kim; Charles R Thomas; William U Shipley; Howard M Sandler
Journal:  Lancet Oncol       Date:  2018-10-10       Impact factor: 41.316

2.  Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.

Authors:  Zachary S Zumsteg; Daniel E Spratt; Paul B Romesser; Xin Pei; Zhigang Zhang; Marisa Kollmeier; Sean McBride; Yoshiya Yamada; Michael J Zelefsky
Journal:  J Urol       Date:  2015-07-10       Impact factor: 7.450

3.  Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.

Authors:  Kiri A Sandler; Ryan R Cook; Jay P Ciezki; Ashley E Ross; Mark M Pomerantz; Paul L Nguyen; Talha Shaikh; Phuoc T Tran; Richard G Stock; Gregory S Merrick; David Jeffrey Demanes; Daniel E Spratt; Eyad I Abu-Isa; Trude B Wedde; Wolfgang Lilleby; Daniel J Krauss; Grace K Shaw; Ridwan Alam; Chandana A Reddy; Daniel Y Song; Eric A Klein; Andrew J Stephenson; Jeffrey J Tosoian; John V Hegde; Sun Mi Yoo; Ryan Fiano; Anthony V D'Amico; Nicholas G Nickols; William J Aronson; Ahmad Sadeghi; Stephen C Greco; Curtiland Deville; Todd McNutt; Theodore L DeWeese; Robert E Reiter; Jonathan W Said; Michael L Steinberg; Eric M Horwitz; Patrick A Kupelian; Christopher R King; Amar U Kishan
Journal:  Eur Urol       Date:  2019-04-13       Impact factor: 20.096

Review 4.  Treatment strategies for high-risk locally advanced prostate cancer.

Authors:  Seth A Rosenthal; Howard M Sandler
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

5.  Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.

Authors:  Paula J Hurley; Debasish Sundi; Brian Shinder; Brian W Simons; Robert M Hughes; Rebecca M Miller; Benjamin Benzon; Sheila F Faraj; George J Netto; Ismael A Vergara; Nicholas Erho; Elai Davicioni; R Jeffrey Karnes; Guifang Yan; Charles Ewing; Sarah D Isaacs; David M Berman; Jennifer R Rider; Kristina M Jordahl; Lorelei A Mucci; Jessie Huang; Steven S An; Ben H Park; William B Isaacs; Luigi Marchionni; Ashley E Ross; Edward M Schaeffer
Journal:  Clin Cancer Res       Date:  2015-10-07       Impact factor: 12.531

Review 6.  Tissue biomarkers for prostate cancer radiation therapy.

Authors:  P T Tran; R K Hales; J Zeng; K Aziz; T Salih; R P Gajula; S Chettiar; N Gandhi; A T Wild; R Kumar; J M Herman; D Y Song; T L DeWeese
Journal:  Curr Mol Med       Date:  2012-07-01       Impact factor: 2.222

7.  The early result of whole pelvic radiotherapy and stereotactic body radiotherapy boost for high-risk localized prostate cancer.

Authors:  Yu-Wei Lin; Li-Ching Lin; Kuei-Li Lin
Journal:  Front Oncol       Date:  2014-10-31       Impact factor: 6.244

8.  Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results.

Authors:  Maurizio Valeriani; Alessia Carnevale; Mattia Falchetto Osti; Vitaliana DE Sanctis; Linda Agolli; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2014-09-26       Impact factor: 3.481

Review 9.  Salvage therapy for prostate cancer after radical prostatectomy.

Authors:  Nicholas G Zaorsky; Jeremie Calais; Stefano Fanti; Derya Tilki; Tanya Dorff; Daniel E Spratt; Amar U Kishan
Journal:  Nat Rev Urol       Date:  2021-08-06       Impact factor: 14.432

10.  A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes.

Authors:  Raymond Wu; Hannah Woodford; Anne Capp; Perry Hunter; Gary Cowin; Keen-Hun Tai; Paul L Nguyen; Peter Chong; Jarad Martin
Journal:  Radiat Oncol       Date:  2015-11-25       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.